The depletion of PCSK9 in tumors increased the intratumoral infiltration of lymphocytes, such as CD8+ cytotoxic T-cells (CTLs), CD4+ T helper (Th) cells, γδT cells and natural killer (NK) cells, thus rendering the tumor responsive to immune checkpoint therapy. Here, PCSK9 is linked to neoplasm.